• 1. Enzymatic asymmetric synthesis of chiral amino acids
  Ya-Ping Xue,Cheng-Hao Cao,Yu-Guo Zheng Chem. Soc. Rev. 2018 47 1516
• 2. Immobilization of l-aspartate oxidase from Sulfolobus tokodaii as a biocatalyst for resolution of aspartate solutions
  Paola D'Arrigo,Chiara Allegretti,Andrea Fiorati,Luciano Piubelli,Elena Rosini,Davide Tessaro,Mattia Valentino,Loredano Pollegioni Catal. Sci. Technol. 2015 5 1106
• 3. Development of a dye molecule-biocatalyst hybrid system with visible-light induced carbon–carbon bond formation from CO2 as a feedstock
  Yutaka Amao,Shusaku Ikeyama,Takayuki Katagiri,Kohei Fujita Faraday Discuss. 2017 198 73
• 4. Anisotropy, segmental dynamics and polymorphism of crystalline biogenic carboxylic acids
  Václav Pokorny,Petr Tou?,Vojtěch ?tejfa,Květoslav R??i?ka,Jan Rohlí?ek,Ji?í Czernek,Ji?í Brus,Ctirad ?ervinka Phys. Chem. Chem. Phys. 2022 24 25904
• 5. Biological approaches to artificial photosynthesis, fundamental processes and theoretical approaches: general discussion
  Vincent Artero,Leif Hammarstr?m,Fengtao Fan,Dong Ryeol Whang,Jose Martinez,Anthony Harriman,Takumi Noguchi,Joshua Karlsson,Peter Summers,Shigeru Itoh,Richard Cogdell,Alexander Kibler,Johannes Ehrmaier,Hitoshi Tamiaki,Etsuko Fujita,Seigo Shima,Shunya Yoshino,Haruo Inoue,Michael Wasielewski,Thomas Corry,Devens Gust,Flavia Cassiola,Hitoshi Ishida,Katsuhiko Takagi,Sang Ook Kang,Can Li,Licheng Sun,Hyunwoong Park,Hideki Hashimoto,Yutaka Amao,Eun Jin Son,Nobuo Kamiya,Jian-Ren Shen,Kizashi Yamaguchi Faraday Discuss. 2017 198 147

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Keto acids and derivatives Short-chain keto acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Oxaloacetic Acid: A Comprehensive Overview

Oxaloacetic acid, also known by its CAS number 328-42-7, is a naturally occurring organic compound that plays a significant role in various biochemical pathways. It is a dicarboxylic acid with the molecular formula C4H6O5 and is commonly found in plants, particularly in the leaves, where it serves as an intermediate in the tricarboxylic acid (TCA) cycle and the glyoxylate cycle. Oxaloacetic acid is also involved in gluconeogenesis, a metabolic pathway that generates glucose from non-carbohydrate precursors.

Recent studies have highlighted the importance of oxaloacetic acid in cellular metabolism and its potential therapeutic applications. For instance, research has shown that oxaloacetic acid can act as a precursor for the synthesis of other essential biomolecules, such as citrate and malate, which are critical for energy production in cells. Furthermore, oxaloacetic acid has been implicated in the regulation of oxidative stress and inflammation, making it a promising candidate for the development of novel anti-inflammatory and antioxidant therapies.

In terms of industrial applications, oxaloacetic acid is widely used as a precursor in the synthesis of various organic compounds, including amino acids and pharmaceuticals. Its ability to participate in multiple metabolic pathways makes it a valuable intermediate in biotechnology and chemical manufacturing. Recent advancements in metabolic engineering have enabled the efficient production of oxaloacetic acid through microbial fermentation, which has significantly reduced production costs and improved scalability.

The structural properties of oxaloacetic acid also contribute to its versatility in biochemical systems. Its two carboxylic acid groups allow it to participate in various enzymatic reactions, including decarboxylation and transamination. These reactions are essential for maintaining cellular homeostasis and ensuring proper energy metabolism. Recent research has focused on understanding the role of oxaloacetic acid in mitochondrial function and its potential implications for neurodegenerative diseases such as Alzheimer's disease.

Moreover, oxaloacetic acid has been shown to exhibit anti-diabetic properties by enhancing insulin sensitivity and improving glucose metabolism. Studies have demonstrated that supplementation with oxaloacetic acid can reduce blood glucose levels and improve lipid profiles in diabetic animal models. These findings suggest that oxaloacetic acid could be a potential therapeutic agent for managing metabolic disorders associated with insulin resistance.

In conclusion, oxaloacetic acid (CAS No. 328-42-7) is a multifunctional compound with significant roles in cellular metabolism, energy production, and disease prevention. Its versatility as a biochemical intermediate and its emerging therapeutic applications make it an area of active research interest. As our understanding of its molecular mechanisms continues to grow, oxaloacetic acid is poised to play an even more critical role in both basic science and applied medicine.

• 24567-12-2(Butanedioic acid, oxo-, sodium salt)
• 300-01-6(Butanedioic acid,2-oxo-, sodium salt (1:2))
• 5699-58-1(Acetylpyruvic Acid)
• 59866-21-6(Butanedioic acid,2-oxo-, magnesium salt (1:1))
• 4374-46-3(Butanoic acid, 2,3-dioxo- (9CI))
• 7619-04-7(2-Butenedioic acid, 2-hydroxy-)
• 1069-50-7(Butanoic acid,2,4-dioxo-)
• 7580-59-8(2,3-Dioxosuccinic acid)
• 149-63-3(Butanedioic acid,2-oxo-, ion(2-))
• 5617-54-9(Heptanedioic acid,2,4,6-trioxo-)